WASATCH ADVISORS LP 13D and 13G filings for Flexion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-09 3:34 pm Sale | 2021-11-09 | 13G | Flexion Therapeutics, Inc. FLXN | WASATCH ADVISORS LP | 0 0.000% | -4,109,494 (Position Closed) | Filing |
| 2021-02-11 2:40 pm Purchase | 2021-02-11 | 13G | Flexion Therapeutics, Inc. FLXN | WASATCH ADVISORS LP | 4,109,494 8.300% | 1,940,637 (+89.48%) | Filing |
| 2020-02-10 1:18 pm Purchase | 2020-02-10 | 13G | Flexion Therapeutics, Inc. FLXN | WASATCH ADVISORS LP | 2,168,857 5.700% | 2,168,857 (New Position) | Filing |